Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin beta in cardiac arrest victims
2006-006453-27Phase 2Completed
- Sponsor
- Zdravstveni dom dr. Adolfa Drolca Maribor
- Start
- Jan 2007
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of epoetin beta in cardiac arrest (SCA) (2 arms), sponsored by Zdravstveni dom dr. Adolfa Drolca Maribor. Primary endpoint: Survival and neurological outcome. Started Jan 2007; status: completed.
02
Drugs
epoetin beta
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2006-006453-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006453-27.